Clinical trial · Observational
Molecular Characterization of Cutaneous Tumors
NCT03092830CI-TRIAL-00038389unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective is to find genes which are responsible for the appearance of skin tumors (sCC, BCC) and it will be the basis for prediction of the disease and response to the treatment
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Basal Cell Carcinoma | Basal Cell Carcinoma | ONTOLOGY_EXACT | 0.90 |
| Squamous Cell Carcinoma | Squamous Cell Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Molecular testing of DNA/RNA from skin tumors, SCC/BCC | Genetic | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- 1-arm, 500 participates
- description
- Molecular testing of DNA/RNA from skin tumors, SCC/BCC
- interventionNames
- Genetic: Molecular testing of DNA/RNA from skin tumors, SCC/BCC
Primary outcomes (1)
- measure
- Molecular Characterization of cutaneous tumors
- timeFrame
- 5 years
- description
- samples from subjects
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patient that have sCC and BCC tumors * above 18 years old Exclusion Criteria: * below 18 years old * pregnant women * children or person without judgment ability
References
Publications (1)
- BACKGROUNDWinder M, Viros A. Mechanisms of Drug Resistance in Melanoma. Handb Exp Pharmacol. 2018;249:91-108. doi: 10.1007/164_2017_17. PMID 28275910